Inventor · disambiguated record
Lisa Bond Moritz
Also filed as: BOND MORITZ LISA
8 granted patents·1 pending application·20 citations·filing 2017–2024
81Inventor score
Files withBIOAXONE BIOSCIENCES INC9
Top patents by PatentIndex Score
9 records- 0193US10106525B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·11 cites·3 claims
- 0290US10149856B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Dec 11, 2018·6 cites·6 claims
- 0388US10526313B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Jan 7, 2020·3 cites·2 claims
- 0485US12384759B2Rho kinase inhibitor ba-1049 (r) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2023·Granted Aug 12, 2025·0 cites·18 claims
- 0578US2024299409A1Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0671US11814361B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2021·Granted Nov 14, 2023·0 cites·14 claims
- 0770US10857157B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Dec 8, 2020·0 cites·14 claims
- 0868US11701366B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Jul 18, 2023·0 cites·7 claims
- 0965US11198680B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Dec 14, 2021·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →